CME Group Inc.
BG ˙ BUL ˙ US12572Q1058
SecurityBG:MX4A / CME Group Inc.
InstitutionBoston Private Wealth Llc
Latest Disclosed Ownership10,368 shares
Latest Disclosed Value $ 3,062,342
Boston Private Wealth Llc reports 7.53% increase in ownership of MX4A / CME Group Inc.

On April 17, 2026 - Boston Private Wealth Llc filed a 13F-HR form disclosing ownership of 10,368 shares of CME Group Inc. (BG:MX4A) valued at $3,062,342 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 9,642 shares of CME Group Inc.. This represents a change in shares of 7.53% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-17 2026-03-31 13F CME GROUP INC COM COM 12572Q105 10,368 726 7.53 3,062 16.29 0.0538
2026-02-04 2025-12-31 13F CME GROUP INC COM COM 12572Q105 9,642 1,296 15.53 2,633 16.81 0.1552
2025-11-06 2025-09-30 13F CME GROUP INC COM COM 12572Q105 8,346 -41 -0.49 2,255 -2.47 0.1213
2025-08-14 2025-06-30 13F CME GROUP INC COM COM 12572Q105 8,387 -953 -10.20 2,312 -6.70 0.1238
2025-05-14 2025-03-31 13F CME GROUP INC COM COM 12572Q105 9,340 4,929 111.74 2,478 141.89 0.1018
2025-02-05 2024-12-31 13F CME GROUP INC COM COM 12572Q105 4,411 4,411 1,024 0.0191
2024-10-18 2024-09-30 13F CME GROUP INC COM COM 12572Q105 0 -2,963 -100.00 0 -100.00
2024-08-06 2024-06-30 13F CME GROUP INC COM COM 12572Q105 2,963 -677 -18.60 582 -25.67 0.0144
2024-05-15 2024-03-31 13F CME GROUP INC COM COM 12572Q105 3,640 -318 -8.03 784 -6.00 0.0175
2024-01-30 2023-12-31 13F CME GROUP INC COM COM 12572Q105 3,958 651 19.69 833 26.02 0.0203
2023-10-23 2023-09-30 13F CME GROUP INC COM COM 12572Q105 3,307 -272 -7.60 662 -0.30 0.0145
2023-07-24 2023-06-30 13F CME GROUP INC COM COM 12572Q105 3,579 -1,144 -24.22 663 -26.66 0.0120
2023-05-12 2023-03-31 13F CME GROUP INC COM COM 12572Q105 4,723 -2,162 -31.40 905 -21.87 0.0126
2023-02-10 2022-12-31 13F CME Group COM 12572Q105 6,885 -30,683 -81.67 1,158 -82.61 0.0156
2022-11-09 2022-09-30 13F CME Group COM 12572Q105 37,568 -221 -0.58 6,655 -13.96 0.0972
2022-08-16 2022-06-30 13F CME Group COM 12572Q105 37,789 -458 -1.20 7,735 -14.97 0.1190
2022-05-13 2022-03-31 13F CME Group COM 12572Q105 38,247 -7,026 -15.52 9,097 -12.05 0.1218
2022-02-15 2021-12-31 13F CME Group COM 12572Q105 45,273 849 1.91 10,343 20.39 0.1696
2021-11-09 2021-09-30 13F CME Group COM 12572Q105 44,424 -228 -0.51 8,591 -9.53 0.1104
2021-08-13 2021-06-30 13F CME Group COM 12572Q105 44,652 2,003 4.70 9,496 9.01 0.1204
2021-05-11 2021-03-31 13F CME Group COM 12572Q105 42,649 -2,004 -4.49 8,711 7.16 0.1213
2021-02-10 2020-12-31 13F CME GROUP INC COM COM 12572Q105 44,653 25 0.06 8,129 8.88 0.1193
2020-11-10 2020-09-30 13F CME GROUP INC COM COM 12572Q105 44,628 347 0.78 7,466 3.74 0.1231
2020-08-05 2020-06-30 13F Cme Group Inc. Com COM 12572Q105 44,281 -6,116 -12.14 7,197 -17.41 0.1338
2020-05-11 2020-03-31 13F Cme Group Inc. Com COM 12572Q105 50,397 -5,629 -10.05 8,714 -22.51 0.2115
2020-02-13 2019-12-31 13F Cme Group Inc. Com COM 12572Q105 56,026 -6,866 -10.92 11,246 -15.39 0.2047
2019-11-01 2019-09-30 13F Cme Group Inc. Com COM 12572Q105 62,892 -8,762 -12.23 13,292 -4.44 0.2646
2019-07-10 2019-06-30 13F Cme Group Inc. Com COM 12572Q105 71,654 -13,314 -15.67 13,909 -0.54 0.4672
2019-05-14 2019-03-31 13F Cme Group Inc. Com COM 12572Q105 84,968 -9,440 -10.00 13,984 -21.26 0.5524
2019-02-14 2018-12-31 13F Cme Group Inc. Com COM 12572Q105 94,408 2,558 2.78 17,760 13.61 0.7577
2018-11-13 2018-09-30 13F Cme Group Inc. Com COM 12572Q105 91,850 74,360 425.16 15,633 445.27 0.5529
2018-08-14 2018-06-30 13F Cme Group Inc. Com COM 12572Q105 17,490 14,929 582.94 2,867 592.51 0.1099
2018-05-11 2018-03-31 13F Cme Group Inc. Com COM 12572Q105 2,561 0 0.00 414 10.70 0.0159
2018-02-13 2017-12-31 13F Cme Group Inc. Com COM 12572Q105 2,561 53 2.11 374 10.00 0.0141
2017-11-13 2017-09-30 13F Cme Group Inc. Com COM 12572Q105 2,508 856 51.82 340 64.25 0.0131
2017-08-04 2017-06-30 13F Cme Group Inc. Com COM 12572Q105 1,652 -275 -14.27 207 -9.61 0.0081
2017-05-11 2017-03-31 13F Cme Group Inc. Com COM 12572Q105 1,927 1,927 229 0.0091
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.